sodium thiosulfate has been researched along with Cardiovascular Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, J; Santos, PW; Tuffaha, A; Wetmore, JB | 1 |
Borrajo Prol, M; Camba Caride, M; Conde Rivera, O; Iglesias Lamas, E; López Alarcóon, W; Novoa Fernández, E; Santos Nores, J | 1 |
2 other study(ies) available for sodium thiosulfate and Cardiovascular Diseases
Article | Year |
---|---|
Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy.
Topics: Aged; Anticoagulants; Arterioles; Calciphylaxis; Cardiovascular Diseases; Chelating Agents; Debridement; Diabetes Mellitus; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Registries; Renal Dialysis; Risk Factors; Survival Rate; Thiosulfates; Warfarin | 2017 |
Multidisciplinary treatment. A therapeutic option to treat calciphylaxis.
Topics: Anti-Bacterial Agents; Antiphospholipid Syndrome; Calciphylaxis; Carcinoma, Renal Cell; Cardiovascular Diseases; Cinacalcet; Clostridium Infections; Clostridium perfringens; Combined Modality Therapy; Debridement; Foot Ulcer; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Naphthalenes; Postoperative Complications; Renal Replacement Therapy; Staphylococcal Infections; Thiosulfates | 2011 |